Objective:
To assess the indications and results of airway resection and how frequently airway reconstructive options changed proposed therapy.
Design:
A retrospective survey of patients undergoing major airway resection.
Setting:
University of Washington–affiliated hospitals, Seattle, May 1992 through December 1996.
Patients:
Fifty consecutive patients with resectable benign and malignant tracheal or main bronchial disease undergoing tracheobronchial resections.
Interventions:
Patients underwent major airway resection as follows: tracheal or laryngotracheal resection, 23 patients; carinal resection, 6; and bronchial sleeve resection with or without pulmonary resection, 21. Indications for surgery were non–small cell lung cancer in 19 patients, primary airway tumor in 12, thyroid carcinoma in 1, and tracheal or bronchial stenosis in 18.
Main Outcome Measures:
Change in prereferral planned therapy from palliative to definitive or to pulmonary-sparing procedure, morbidity and mortality, relief of symptoms, and survival.
Results:
Mortality was 0%, and morbidity, 32% (16/50). Airway reconstruction changed the proposed therapy in 42 patients (84%). Functional results were good to excellent in 17 (94%) of 18 patients with benign disease. Patients with malignant disease had a 1-year survival of 93% (27/29) and a 2-year survival of 67% (12/18).
Conclusions:
Airway resection and reconstruction provide reliable relief of benign and malignant tracheobronchial disease with minimal morbidity and mortality. Airway reconstruction frequently changed prereferral planned therapy and provided definitive and parenchymalsparing procedures to patients with complex airway lesions.Arch Surg. 1997;132:850-856